Friday, March 1, 2019

F.D.A. Says Canadian Company, CanaRx, Sells Unsafe Medicines to U.S. Buyers


By SHEILA KAPLAN from NYT Health https://ift.tt/2tFb8HY

No comments:

Post a Comment

A single protein may be holding back CAR T cancer therapy

A newly identified protein may be one of the biggest obstacles holding CAR T-cell therapy back. Researchers found that NFIL3 causes these en...